Administration of indole-3-acetic acid, a gut-microbiota derived metabolite from tryptophan and a well-known AhR agonist obliterated NAFLD parameters by attenuating hepatic lipogenesis, oxidative and inflammatory stress. The gene discussed is AHR; the disease is metabolic dysfunction-associated steatotic liver disease.